Valiant Laboratories (NSE:VALIANTLAB) Deferred Tax: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VALIANTLAB Valiant Laboratories Ltd NSE:VALIANTLAB
53 GF Score
Price ₹105.97
GF Value ₹148.29
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Valiant Laboratories Deferred Tax?

Valiant Laboratories NSE:VALIANTLAB +4.99% 53 Deferred Tax is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:VALIANTLAB with a GF Score™ of 53/100 and a GF Value™ of ₹148.29 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Valiant Laboratories's change in deferred tax for the three months ended in Jun. 2026 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil.

Valiant Laboratories Deferred Tax Related Terms

Valiant Laboratories Deferred Tax Historical Data

* Premium members only.

The historical data trend for Valiant Laboratories's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valiant Laboratories Deferred Tax Chart

Valiant Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Deferred Tax
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Valiant Laboratories Quarterly Data
Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:VALIANTLAB
53GF Score
Valiant Laboratories Ltd NSE:VALIANTLAB
Deferred Tax is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valiant Laboratories Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Deferred Tax →
What does a Deferred Tax of ₹0 Mil mean?
Valiant Laboratories (NSE:VALIANTLAB) has a Deferred Tax of ₹0 Mil as of Jun. 2026. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for Valiant Laboratories.
Is Valiant Laboratories' Deferred Tax too high?
Valiant Laboratories' current Deferred Tax is ₹0 Mil. Overall, Valiant Laboratories has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Valiant Laboratories' Deferred Tax compare to ZTS?
Valiant Laboratories' Deferred Tax of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Deferred Tax for a Drug Manufacturers company?
A good Deferred Tax depends on the Drug Manufacturers industry context. However, Deferred Tax should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Deferred Tax mean?
A high Deferred Tax can signal that a stock is expensive relative to its fundamentals. Change in Defered Tax is amount of deferred tax assets or liabilities due to temporary differences in financial and tax accounting. View historical data for Valiant Laboratories. Valiant Laboratories's current Deferred Tax is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valiant Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Valiant Laboratories (NSE:VALIANTLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹148.29, compared to a current price of ₹105.97 — trading 28.5% below its estimated fair value. The current Deferred Tax is ₹0 Mil. Valiant Laboratories' overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Deferred Tax calculated?
Deferred Tax is calculated from a company's financial statements. For Valiant Laboratories (NSE:VALIANTLAB), the current Deferred Tax is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valiant Laboratories (NSE:VALIANTLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Valiant Laboratories stock appears to be undervalued. The current stock price of ₹105.97 is trading 28.5% below its estimated GF Value™ of ₹148.29. GuruFocus considers Valiant Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:VALIANTLAB:

  • Deferred Tax: ₹0 Mil
  • GF Value™: ₹148.29 vs. price of ₹105.97 (28.5% below fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the NSE:VALIANTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valiant Laboratories Business Description

Other Exchanges 543998:India
Address Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
53GF Score

Get the complete analysis for NSE:VALIANTLAB

Deferred Tax is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹105.97
Price
₹148.29
GF Value